LSPP Development Priorities

Targretin?

Capsules

(CTCL) 

ONTAK?

(CTCL)

Targretin? Gel(CTCL)

NSCLC

Psoriasis

(moderate/

severe)

“Onco-Dose”

B-Cell NHL

“Low Dose Intermittent”

Rheumatoid Arthritis

Psoriasis

(severe)

Hand Dermatitis

(eczema)

Psoriasis

(mild/moderate)

Combination

Monotherapy

All T-Cell NHL

CLL

Previous slide

Next slide

Back to first slide

View graphic version